Veeva Systems Inc. (ETR:VEE)

Verve Therapeutics Revenue

In the fiscal year ending January 31, 2025, Veeva Systems had annual revenue of $2.75B USD with 16.20% growth. Veeva Systems had revenue of $720.89M in the quarter ending January 31, 2025, with 14.31% growth.

• Revenue: $2.75B
• Revenue Growth: +16.20%
• P/S Ratio: 12.51
• Revenue / Employee: $376.71K
• Employees: 7,291
• Market Cap: 33.06B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jan 31, 2025	2.75B	382.95M	16.20%
Jan 31, 2024	2.36B	208.61M	9.68%
Jan 31, 2023	2.16B	304.28M	16.44%
Jan 31, 2022	1.85B	385.71M	26.33%
Jan 31, 2021	1.47B	360.99M	32.70%